[18F]mFBG PET/CT surpasses [18F]FDG PET/CT for evaluation of pediatric neuroblastoma
[<sup>18</sup>F]mFBG PET/CT detected more neuroblastoma lesions than [<sup>18</sup>F]FDG PET/CT, suggesting it may be a more viable alternative when standard [<sup>123</sup>I]MIBG scanning is not feasible.
Authors
- Changchun Li
- Chenxi Zheng (ORCID: https://orcid.org/0009-0003-9490-3031)
- Yoonseok Han (ORCID: https://orcid.org/0000-0002-0266-0614)
- Shan Wang
- Yao Zhang (ORCID: https://orcid.org/0000-0001-8878-891X)
- Liang Cai
- Wenqian Zhang
- Chao Yang
- Zhenni Wang
- Zhenzhen Zhao
- Yalan Xiong (ORCID: https://orcid.org/0009-0000-4377-8793)
- Shunhao Zhou
Institutions
- Dalian Medical University (CN)
- China International Science and Technology Cooperation (CN)
- Second Affiliated Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-09-02
- DOI
- https://doi.org/10.3389/fonc.2025.1627403
- Primary Topic
- Neuroblastoma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00